Finance

Lists
Why is 002349 up 3,33%?
Dive Deeper
002349:SHE
Jinghua Pharmaceutical Group Co Ltd
CN¥8,07
+3,33%
(+0,26) 1D
15 Okt., 10:08:33 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002349...
Open
CN¥7,82
High
CN¥8,29
Low
CN¥7,79
Mkt. cap
7,20 mjd
Avg. vol.
77,64 m
Volume
35,82 m
Dividend
1,12%
Quarterly dividend
CN¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
29,45
52-wk high
CN¥9,59
52-wk low
CN¥5,99
EPS
CN¥0,27
Shares outstanding
831,07 m
No. of employees
1 k
Open
CN¥7,82
High
CN¥8,29
Low
CN¥7,79
Mkt. cap
7,20 mjd
Avg. vol.
77,64 m
Volume
35,82 m
Dividend
1,12%
Quarterly dividend
CN¥0,02
Ex-dividend date
29 Mei 2026
P/E ratio
29,45
52-wk high
CN¥9,59
52-wk low
CN¥5,99
EPS
CN¥0,27
Shares outstanding
831,07 m
No. of employees
1 k
News stories
From web sources and news partners
About Jinghua Pharmaceutical Group Co Ltd
CEO-
Employees1,46 k
Founded1957
Headquarters-
SectorPharmaceutical industry
Websitentjhzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
360,86 m
367,67 m
379,76 m
375,01 m
Cost of goods sold
173,69 m
196,06 m
169,42 m
180,05 m
Cost of revenue
173,69 m
196,06 m
169,42 m
180,05 m
Research and development expenses
14,70 m
21,45 m
14,29 m
15,92 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
105,07 m
99,33 m
96,62 m
83,95 m
Operating expense
124,89 m
125,31 m
117,85 m
105,08 m
Total operating expenses
298,58 m
321,37 m
287,26 m
285,13 m
Operating income
62,29 m
46,30 m
92,50 m
89,88 m
Other non operating income
-1,59 m
1,52 m
-1,88 m
1,75 m
EBT including unusual items
67,91 m
60,56 m
94,49 m
98,29 m
EBT excluding unusual items
70,73 m
51,60 m
96,39 m
92,68 m
Income tax expense
10,05 m
8,28 m
12,74 m
14,80 m
Effective tax rate
14,79%
13,66%
13,49%
15,05%
Other operating expenses
5,43 m
4,59 m
5,10 m
5,40 m
Net income
45,73 m
42,91 m
65,87 m
70,25 m
Net profit margin
12,67%
11,67%
17,35%
18,73%
Earnings per share
-
-
-
-
Interest and investment income
9,58 m
6,44 m
5,88 m
5,53 m
Interest expense
-
-115,63 k
-116,59 k
-399,11 k
Net interest expenses
9,58 m
6,33 m
5,77 m
5,13 m
Depreciation and amortization charges
-
-
-
-
EBITDA
81,02 m
66,16 m
112,36 m
108,77 m
Gain or loss from assets sale
28,38 k
5,09 k
-
-7,11 k
AI content may include mistakes. Learn more
Google-programme